NEWS

NEW FRONTIERS IN CANCER TREATMENT

AACR Poster Presentation: “KSQ-001: A CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL™) Therapy for Solid Tumors

Click to download PDF file.

View All Press Releases